Video: Dr. Casella reviews vitamin B3 for glaucoma management

A world-first clinical trial led by the Centre for Eye Research Australia shows vitamin B3 (nicotinamide) could play an important role in protecting against nerve cell damage that leads to blindness in glaucoma patients. Chief Optometric Editor, Ben Casella, OD, FAAO, says it's exciting news, but more research needs to be done.

Related: Glaucoma & ocular surface preservation: Key factors for ODs to consider

Related Videos
© 2023 MJH Life Sciences

All rights reserved.